CORDLIFE GROUP LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.129 SGD | +3.20% |
|
+4.88% | -59.05% |
| 18/04 | Cordlife Group Lodges Police Report Against Former Staff Over Cryogenic Tank Incident | MT |
| 17/04 | Cordlife Enters Subscription Agreements | MT |
| Sales 2021 | 56.67M 41.59M 3.47B | Sales 2022 | 55.16M 40.48M 3.38B | Capitalization | 81.91M 60.12M 5.01B |
|---|---|---|---|---|---|
| Net income 2021 | 6M 4.4M 367M | Net income 2022 | 4M 2.94M 245M | EV / Sales 2021 | 0.71 x |
| Net cash position 2021 | 61.98M 45.49M 3.79B | Net cash position 2022 | 63.75M 46.79M 3.9B | EV / Sales 2022 | 0.33 x |
| P/E ratio 2021 |
16.7
x | P/E ratio 2022 |
16.8
x | Employees | 538 |
| Yield 2021 |
2.25% | Yield 2022 |
-
| Free-Float | 31.7% |
More Fundamentals
* Assessed data
More news
| 1 day | +3.20% | ||
| 1 week | +4.88% | ||
| Current month | -25.00% | ||
| 1 month | -28.33% | ||
| 3 months | -57.70% | ||
| 6 months | -71.96% | ||
| Current year | -59.05% |
1 week
0.12
0.15
1 month
0.120.17
Current year
0.120.32
1 year
0.120.57
3 years
0.120.57
5 years
0.120.63
10 years
0.121.72
| Managers | Title | Age | Since |
|---|---|---|---|
Hnin Yi Thet
DFI | Director of Finance/CFO | 48 | 01/11/01 |
Huiying Tan
COO | Chief Operating Officer | - | 01/13/01 |
Stella Mei Suan
PRN | Corporate Officer/Principal | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hwee Tiong Yeo
BRD | Director/Board Member | 68 | 22/18/22 |
Choon Hou Ho
CHM | Chairman | 52 | 16/11/16 |
Wai Leung Wong
BRD | Director/Board Member | 64 | 23/14/23 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 0.129 | +3.20% | 127,000 |
| 25/24/25 | 0.125 | -0.79% | 54,500 |
| 24/24/24 | 0.126 | +3.28% | 436,500 |
| 23/24/23 | 0.122 | +1.67% | 1,598,400 |
| 22/24/22 | 0.12 | -2.44% | 248,700 |
Delayed Quote Singapore S.E., April 26, 2024 at 02:34 pm IST
More quotes
Cordlife Group Limited is a Singapore-based company that owns cord blood banks in Asia with full stem cell banking facilities in Singapore, Hong Kong, Indonesia, the Philippines, India and Malaysia. The Companyâs segments include Banking and Diagnostics. The banking segment comprises the collection, processing and banking of biological materials. The diagnostics segment comprises diagnostics testing services. Its banking services include cord blood, cord lining, cord lining mesenchymal stem cells, corneal lenticule, cord lining epithelial stem cells, cord tissue and others. Its diagnostic testing services include newborn genetic screening, pediatric vision screening, pediatric ear screening, pediatric allergen test, genetic talent test, preimplantation genetic screening, endometrial receptivity test, non-invasive prenatal testing and newborn metabolic screening. Its MOMS UP is a mobile app offering pregnancy, as well as parenting resources for moms and moms-to-be in Asia.
Calendar
10/05/2024
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -59.05% | 24.26M | |
| -14.92% | 84.68B | |
| +13.30% | 81.12B | |
| +10.92% | 29.4B | |
| -12.71% | 16.73B | |
| -3.06% | 16.36B | |
| -2.63% | 14.92B | |
| -31.75% | 11.77B | |
| -1.42% | 11.72B | |
| +27.44% | 11.71B |
- Stock Market
- Equities
- P8A Stock
